The AST/ALT ratio, sometimes called the De Ritis ratio, compares the blood levels of two enzymes released when liver cells are damaged. In a healthy adult, it sits around 0.8. When the ratio shifts, the direction and magnitude give clinicians surprisingly useful clues about what is happening inside the liver and, in some cases, outside it entirely. A ratio below 1 points toward certain conditions, a ratio above 1 toward others, and a ratio above 2 narrows the possibilities even further. But context matters enormously: age, sex, medications, recent exercise, and even the way a blood sample is handled can all push the number around.
General Ranges and What They Suggest
The ratio is calculated by dividing the AST value by the ALT value on a standard blood panel. In healthy people, that number typically hovers around 0.8.1Toxicology Reports. Insights into medication-induced liver injury: Understanding and management strategies Here is what the common ranges generally indicate:
- Below 1: ALT is higher than AST. This pattern is typical of mild to moderate liver cell injury where the liver is inflamed but not yet severely scarred, as in fatty liver disease or early chronic hepatitis.
- Around 1: The enzymes are roughly equal. In chronic liver disease, a ratio approaching or crossing 1 can signal that fibrosis is progressing toward cirrhosis.
- Above 1 but below 2: AST has overtaken ALT. This raises suspicion for advancing fibrosis, cirrhosis, or certain non-liver causes that preferentially release AST.
- Above 2: Strongly associated with alcohol-related liver damage, though it can also appear in heart attacks and severe cirrhosis from any cause.
These ranges are guidelines, not hard cutoffs. A single ratio in isolation tells you little. Its value comes from the clinical picture it fits into and how it changes over time.
Why AST and ALT Behave Differently
Both AST and ALT are enzymes found inside liver cells, and both spill into the bloodstream when those cells are injured. The key difference is where else each enzyme lives. ALT is concentrated almost exclusively in the liver, making it a more specific marker for liver damage. AST, by contrast, also exists in the heart, skeletal muscle, kidneys, and red blood cells. When you see AST climbing out of proportion to ALT, the source of that extra AST may not be the liver at all.
There is also a timing difference that shapes the ratio. AST has a half-life in the blood of about 18 hours, while ALT lingers for roughly 36 hours.2PubMed Central. The de ritis ratio: the test of time After an acute injury, both enzymes flood the bloodstream, but AST clears faster. This means the ratio shifts as days pass after an insult, and clinicians can use that shift to gauge whether a patient is recovering or getting worse.
Fatty Liver Disease and a Ratio Below 1
Non-alcoholic fatty liver disease is one of the most common reasons you will see ALT running higher than AST. When fat accumulates in liver cells and triggers low-grade inflammation, ALT tends to rise more prominently. A large cross-sectional study of American adults found a strong association between a higher ALT/AST ratio (the inverse of the De Ritis ratio) and the risk of fatty liver disease. People in the highest quartile of ALT relative to AST had more than three times the odds of having fatty liver compared to those in the lowest quartile.3PubMed Central. Elevated ALT/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the United States
In practical terms, if your blood work shows a ratio well below 1 and you have risk factors like obesity or metabolic syndrome, your doctor is likely thinking about fatty liver as a possibility. This ALT-dominant pattern is considered relatively reassuring in one sense: it usually means the liver has not yet progressed to severe scarring. But it is not a free pass, because fatty liver can advance over years if the underlying metabolic drivers are not addressed.
Cirrhosis and the Rising Ratio
One of the ratio’s most clinically validated uses is flagging the transition from chronic liver disease to cirrhosis. In chronic hepatitis B without cirrhosis, for example, the average ratio has been measured at about 0.59. When cirrhosis develops, that average jumps to roughly 1.02.4Gastroenterology. Ratio of Serum Aspartate to Alanine Aminotransferase in Chronic Hepatitis Relationship to Cirrhosis The finding holds up in hepatitis C as well: in one study, cirrhotic patients had a mean ratio of about 1.06, while non-cirrhotic patients averaged 0.60. A ratio at or above 1 had perfect specificity and positive predictive value for identifying cirrhosis in that group, meaning that every patient whose ratio reached 1 actually had cirrhosis confirmed on biopsy.5PubMed. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection
Why does cirrhosis flip the ratio? As the liver becomes increasingly scarred, its ability to clear AST from the bloodstream decreases, and the damaged architecture of the organ releases more AST relative to ALT. The ratio also correlates positively with the stage of fibrosis, making it a rough gauge of how far along the scarring process is.6Journal La Medihealtico. Evaluation of the AST/ALT Ratio as a Non-Invasive Predictor of Chronic Liver Disease This is one reason clinicians pay attention when a patient with known chronic hepatitis shows a ratio that is creeping upward over serial blood tests.
Alcohol-Related Liver Disease
The classic teaching is that a ratio above 2 points strongly toward alcohol as the cause of liver damage. In alcoholic hepatitis, AST climbs much higher than ALT, and values above 2 are common. The ratio can exceed 3 in severe cases. This pattern was recognized early in the history of the De Ritis ratio and remains one of its best-known clinical applications.2PubMed Central. The de ritis ratio: the test of time
However, the rule is not as reliable as textbooks sometimes imply. Several days after someone stops drinking, ALT can rebound and the ratio may drop below 2 or even below 1. The same review that popularized the alcohol-ratio association also cautioned that alcoholic hepatitis can have ALT higher than AST when enough time has passed since the last drink.2PubMed Central. The de ritis ratio: the test of time Similarly, in acute viral hepatitis, ALT usually dominates, but AST can exceed ALT in fulminant cases, which can mimic the alcohol pattern. The lesson is that the ratio hints at a diagnosis but never confirms one on its own.
Acute Injury and Recovery Tracking
In acute liver injuries, such as a paracetamol (acetaminophen) overdose, both AST and ALT spike dramatically. The ratio itself may not help distinguish the cause during the peak. But during recovery, the difference in half-lives becomes a useful tracking tool. Because AST clears from the blood about twice as fast as ALT, a falling AST/ALT ratio is a reassuring sign that the liver is healing. One study of paracetamol poisoning found that when the ratio dropped to 0.4 or below, it was 99% sensitive for identifying patients whose liver enzymes were on their way back down.7PubMed. Can AST/ALT ratio indicate recovery after acute paracetamol poisoning?
This application is particularly useful in emergency and toxicology settings, where clinicians need to decide whether a patient’s liver is getting better or still deteriorating. A ratio that stays elevated or rises again after an initial drop is a red flag suggesting ongoing damage.
Non-Liver Causes of a Skewed Ratio
Because AST is present in tissues beyond the liver, several non-hepatic conditions can push the ratio upward and lead to confusion.
Strenuous exercise is one of the most common culprits. A study of healthy men put through intense muscular exercise found that AST, ALT, and several other markers all rose significantly and stayed elevated for at least a week afterward.8PubMed Central. Muscular exercise can cause highly pathological liver function tests in healthy men Since muscle cells are packed with AST, a hard workout, a fall, or even an intramuscular injection can produce abnormal liver test results that have nothing to do with the liver. If you have recently done intense physical activity before a blood draw, mention it to your doctor.
Hemolysis, the breakdown of red blood cells, is another common confounder. Red blood cells contain AST, and when they rupture, either inside the body (as in sickle cell disease) or during blood collection, AST levels rise disproportionately. In one study of sickle cell patients, over 95% had an AST/ALT ratio above 1, yet most did not have actual liver dysfunction.9Clinical Medicine Insights: Blood Disorders. Pattern of AST and ALT changes in Relation to Hemolysis in sickle cell Disease Even in the lab, severely hemolyzed blood samples can show AST increases of roughly 2.5-fold, far outpacing the modest bump in ALT from the same sample damage.10Biochemia Medica. Effects of hemolysis interference on routine biochemistry parameters
Then there is macro-AST, a benign phenomenon where AST molecules bind to immunoglobulins in the blood, forming large complexes that the body clears slowly. The result is a persistently elevated AST level that looks alarming on paper but does not reflect real tissue damage.11The Guthrie Clinic Journal of Medicine. Unexplained Isolated AST Elevation: A Case of Macro-AST and a Brief Review of Literature Macro-AST can cause significant diagnostic confusion, especially in patients with chronic liver conditions where elevated AST is expected for different reasons.12PubMed Central. Macro-aspartate Aminotransferase: Misleading Finding in a Patient with Non-alcoholic Fatty Liver Disease In people who are otherwise healthy with an isolated AST elevation and no symptoms, macro-AST has been estimated to account for a striking proportion of cases, with some reports putting the figure as high as 40% to 100% depending on the population studied.13PubMed Central. Importance Of Laboratory Detection Of Macro-Aspartate Aminotransferase
Clinical Scoring Systems That Incorporate the Ratio
The raw AST/ALT ratio is informative, but clinicians have built it into more sophisticated scoring tools that combine it with other lab values. Two of the most widely used are APRI (the AST-to-platelet ratio index) and FIB-4 (which factors in AST, ALT, platelet count, and the patient’s age). Both were designed to estimate liver fibrosis without requiring a biopsy, and current clinical guidelines endorse using these serum-based scores as a first-pass screening tool before ordering more expensive imaging like elastography.14PubMed Central. Noninvasive Detection of Clinically Significant Fibrosis in Biopsy-Proven MASLD: A Retrospective Cross-Sectional Diagnostic Accuracy Study
These scores have value beyond initial fibrosis screening. In autoimmune hepatitis, for instance, higher baseline APRI and FIB-4 scores were independently associated with relapse after treatment. Patients with a FIB-4 above roughly 3.8 had about seven times the odds of relapsing compared to those with lower scores.15PubMed Central. Fibrosis-4 and Aspartate Aminotransferase-to-Platelet Ratio Index as Predictors of Relapse in Autoimmune Hepatitis: A Retrospective Single-Center Study These composite scores do not replace imaging or biopsy, but they are cheap, fast, and available anywhere a basic blood count and liver panel can be drawn.
How Age and Sex Shift the Baseline
Not everyone starts from the same baseline. In children and young adolescents, AST tends to be higher relative to ALT, producing a naturally elevated ratio that declines with age. A large Korean study of children found that the AST/ALT ratio was consistently higher in girls than in boys and decreased gradually as children grew older, with more variability in the upper percentile groups.16PubMed Central. Updated reference ranges for aminotransferase levels of Korean children and young adolescents based on the risk factors for metabolic syndrome A pediatric ratio above 1 that would raise alarm in an adult may be perfectly normal in a child.
Sex-based differences in ALT persist into adulthood. In adolescent females, ALT shows a linear relationship with age, and body composition metrics like BMI and waist-to-hip ratio independently predict ALT levels in both sexes.17PubMed Central. Gender Differences in Healthy Ranges for Serum Alanine Aminotransferase Levels in Adolescence Updated reference data from metabolically healthy adults confirm that in men, cholesterol, triglycerides, and BMI are all independently linked to ALT, while in women, age and fasting glucose also play a role.18Clinical Gastroenterology and Hepatology. Updated Reference Intervals for Alanine Aminotransferase in a Metabolically and Histologically Normal Population The practical takeaway is that a “normal” AST/ALT ratio depends partly on who you are. A ratio of 1.1 in a lean 25-year-old man with no metabolic risk factors means something different than the same number in a 70-year-old woman with diabetes.
When Non-Hepatic Causes Should Be on the Radar
If your AST and ALT are both elevated but your doctor cannot find an obvious liver explanation, the search should expand beyond the liver itself. Common non-hepatic causes of abnormal transaminases include muscle disorders, acute muscle injury from trauma or intense exercise, thyroid problems, and heart damage.19PubMed Central. Elevated Alt and Ast in an Asymptomatic Person: What the primary care doctor should do? Your doctor may order a creatine kinase test alongside the liver panel to check whether muscle is the source. If CK is elevated alongside AST but ALT is normal or only mildly raised, the liver is probably not the issue.
Thyroid dysfunction is an underappreciated cause. Both hypothyroidism and hyperthyroidism can raise liver enzymes, and treating the thyroid condition usually normalizes the numbers. Medications are another routine consideration. Statins, certain antibiotics, antiepileptic drugs, and many herbal supplements can push transaminases up in patterns that may or may not affect the ratio, depending on whether they primarily damage liver cells or also affect muscle tissue.
The Ratio as a Mortality Marker Beyond the Liver
Research over the past decade has shown that the AST/ALT ratio can carry prognostic weight that extends well beyond liver disease. A study of Chinese adults with hypertension found that a higher ratio was independently associated with increased risk of death from any cause and from cardiovascular disease specifically. People in the highest third of AST/ALT ratios had roughly twice the risk of dying from any cause and nearly twice the risk of cardiovascular death compared to those in the lowest third.20PubMed Central. The association between AST/ALT ratio and all-cause and cardiovascular mortality in patients with hypertension
The mechanism behind this association is not fully settled, but there are reasonable explanations. An elevated ratio may reflect subclinical cardiac muscle damage, since the heart is rich in AST. It might also be a marker for underlying metabolic dysfunction, chronic low-grade inflammation, or early fibrosis that has not yet been diagnosed. Whatever the pathway, the finding adds another dimension to this simple blood test ratio and suggests it may eventually have a role in general risk stratification, not just hepatology clinics.
What a Single Ratio Cannot Tell You
The temptation with a clean numerical ratio is to treat it like a diagnosis. It is not one. The AST/ALT ratio is a screening signal, a piece of the puzzle that needs to be interpreted alongside the absolute values of both enzymes, other liver tests like GGT and alkaline phosphatase, platelet counts, imaging findings, and the patient’s history. A ratio of 1.3 in someone who ran a marathon two days ago means something entirely different from the same ratio in someone with hepatitis C and falling platelets.
Trends over time are almost always more informative than a single snapshot. A ratio that has been slowly climbing over months in a patient with chronic liver disease is a much stronger signal of progressing fibrosis than a one-off elevated result. If your blood work comes back with an unexpected ratio, the most useful next step is usually a repeat test in a few weeks under controlled conditions: no intense exercise beforehand, no recent alcohol, and ideally fasting. That repeat, compared against the first result, tells a much clearer story than any chart can on its own.